Precancerous Cervical Dysplasia
1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102:3 8.
2. Ferenczy A, Franco EL. Prophylactic human papillomavirus vaccines: potential for sea change. Expert Rev. Vaccines 2007; 6(4 ): 511-525.
Unmet Clinical Needs
Patients with cervical precancerous lesions are mainly treated with traditional surgical methods. Safe and effective alternate treatment options are urgently needed.
Limitations of Traditional Surgical Treatment
APL-1702 is a drug-device combination photodynamic therapy product.
For non-surgical treatment of cervical high-grade squamous intraepithelial lesions (HSIL) caused by any HPV subtypes.
Easy to administer and absorb, not restricted by medical facilities and environment., and with good patient compliance.
High Market Demand
2020-2030 HSIL Patients Worldwide
2020-2030 HSIL Patients in China
Data source: Frost & Sullivan